BACKGROUND: Numerous meta-analyses have investigated the effect of exercise in different populations and for single cardiovascular risk factors, but none have specifically focused on the metabolic syndrome (MetS) patients and the concomitant effect of exercise on all associated cardiovascular risk factors. OBJECTIVE: The aim of this article was to perform a systematic review with a meta-analysis of randomized and clinical controlled trials (RCTs, CTs) investigating the effect of exercise on cardiovascular risk factors in patients with the MetS. METHODS: RCTs and CTs ≥4 weeks investigating the effect of exercise in healthy adults with the MetS and published in a peer-reviewed journal up to November 2011 were included. Primary outcome measures were changes in waist circumference (WC), systolic and diastolic blood pressure, high-density lipoprotein cholesterol (HDL-C), triglycerides and fasting plasma glucose. Peak oxygen uptake ([Formula: see text]) was a secondary outcome. Random and fixed-effect models were used for analyses and data are reported as means and 95% confidence intervals (CIs). RESULTS: Seven trials were included, involving nine study groups and 206 participants (128 in exercise group and 78 in control group). Significant mean reductions in WC -3.4 (95% CI -4.9, -1.8) cm, blood pressure -7.1 (95% CI -9.03, -5.2)/-5.2 (95% CI -6.2, -4.1) mmHg and a significant mean increase in HDL-C +0.06 (95% CI +0.03, +0.09) mmol/L were observed after dynamic endurance training. Mean plasma glucose levels -0.31 (95% CI -0.64, 0.01; p = 0.06) mmol/L and triglycerides -0.05 (95% CI -0.20, 0.09; p = 0.47) mmol/L remained statistically unaltered. In addition, a significant mean improvement in [Formula: see text] of +5.9 (95% CI +3.03, +8.7) mL/kg/min or 19.3% was found. CONCLUSIONS: Our results suggest that dynamic endurance training has a favourable effect on most of the cardiovascular risk factors associated with the MetS. However, in the search for training programmes that optimally improve total cardiovascular risk, further research is warranted, including studies on the effects of resistance training and combined resistance and endurance training.
BACKGROUND: Numerous meta-analyses have investigated the effect of exercise in different populations and for single cardiovascular risk factors, but none have specifically focused on the metabolic syndrome (MetS) patients and the concomitant effect of exercise on all associated cardiovascular risk factors. OBJECTIVE: The aim of this article was to perform a systematic review with a meta-analysis of randomized and clinical controlled trials (RCTs, CTs) investigating the effect of exercise on cardiovascular risk factors in patients with the MetS. METHODS: RCTs and CTs ≥4 weeks investigating the effect of exercise in healthy adults with the MetS and published in a peer-reviewed journal up to November 2011 were included. Primary outcome measures were changes in waist circumference (WC), systolic and diastolic blood pressure, high-density lipoprotein cholesterol (HDL-C), triglycerides and fasting plasma glucose. Peak oxygen uptake ([Formula: see text]) was a secondary outcome. Random and fixed-effect models were used for analyses and data are reported as means and 95% confidence intervals (CIs). RESULTS: Seven trials were included, involving nine study groups and 206 participants (128 in exercise group and 78 in control group). Significant mean reductions in WC -3.4 (95% CI -4.9, -1.8) cm, blood pressure -7.1 (95% CI -9.03, -5.2)/-5.2 (95% CI -6.2, -4.1) mmHg and a significant mean increase in HDL-C +0.06 (95% CI +0.03, +0.09) mmol/L were observed after dynamic endurance training. Mean plasma glucose levels -0.31 (95% CI -0.64, 0.01; p = 0.06) mmol/L and triglycerides -0.05 (95% CI -0.20, 0.09; p = 0.47) mmol/L remained statistically unaltered. In addition, a significant mean improvement in [Formula: see text] of +5.9 (95% CI +3.03, +8.7) mL/kg/min or 19.3% was found. CONCLUSIONS: Our results suggest that dynamic endurance training has a favourable effect on most of the cardiovascular risk factors associated with the MetS. However, in the search for training programmes that optimally improve total cardiovascular risk, further research is warranted, including studies on the effects of resistance training and combined resistance and endurance training.
Authors: Brian A Irving; J Y Weltman; James T Patrie; Christopher K Davis; David W Brock; Damon Swift; Eugene J Barrett; Glenn A Gaesser; Arthur Weltman Journal: J Clin Endocrinol Metab Date: 2009-03-24 Impact factor: 5.958
Authors: Sarah E Seiler; Timothy R Koves; Jessica R Gooding; Kari E Wong; Robert D Stevens; Olga R Ilkayeva; April H Wittmann; Karen L DeBalsi; Michael N Davies; Lucas Lindeboom; Patrick Schrauwen; Vera B Schrauwen-Hinderling; Deborah M Muoio Journal: Cell Metab Date: 2015-07-07 Impact factor: 27.287
Authors: Clemens Drenowatz; Xuemei Sui; Stacy Fritz; Carl J Lavie; Paul F Beattie; Timothy S Church; Steven N Blair Journal: J Sci Med Sport Date: 2014-09-22 Impact factor: 4.319
Authors: Esmée A Bakker; Duck-Chul Lee; Xuemei Sui; Thijs M H Eijsvogels; Francisco B Ortega; I-Min Lee; Carl J Lavie; Steven N Blair Journal: Mayo Clin Proc Date: 2018-02-08 Impact factor: 7.616
Authors: Esmée A Bakker; Duck-Chul Lee; Xuemei Sui; Enrique G Artero; Jonatan R Ruiz; Thijs M H Eijsvogels; Carl J Lavie; Steven N Blair Journal: Mayo Clin Proc Date: 2017-06-13 Impact factor: 7.616
Authors: Dominique Hansen; Josef Niebauer; Veronique Cornelissen; Olga Barna; Daniel Neunhäuserer; Christoph Stettler; Cajsa Tonoli; Eugenio Greco; Robert Fagard; Karin Coninx; Luc Vanhees; Massimo F Piepoli; Roberto Pedretti; Gustavo Rovelo Ruiz; Ugo Corrà; Jean-Paul Schmid; Constantinos H Davos; Frank Edelmann; Ana Abreu; Bernhard Rauch; Marco Ambrosetti; Simona Sarzi Braga; Paul Beckers; Maurizio Bussotti; Pompilio Faggiano; Esteban Garcia-Porrero; Evangelia Kouidi; Michel Lamotte; Rona Reibis; Martijn A Spruit; Tim Takken; Carlo Vigorito; Heinz Völler; Patrick Doherty; Paul Dendale Journal: Sports Med Date: 2018-08 Impact factor: 11.136
Authors: James A Blumenthal; Patrick J Smith; Stephanie Mabe; Alan Hinderliter; Kathleen Welsh-Bohmer; Jeffrey N Browndyke; Pao-Hwa Lin; William Kraus; P Murali Doraiswamy; James Burke; Andrew Sherwood Journal: Psychosom Med Date: 2017 Jul/Aug Impact factor: 4.312
Authors: Oscar Niño; Natalia Balagué; Daniel Aragonés; Juan Alamo; Guillermo Oviedo; Casimiro Javierre; Elisabet Guillamo; Maria C Delicado; Gines Viscor; Josep L Ventura Journal: Eur J Appl Physiol Date: 2017-09-13 Impact factor: 3.078
Authors: Jan Kretzschmar; Dianne M Babbitt; Keith M Diaz; Deborah L Feairheller; Kathleen M Sturgeon; Amanda M Perkins; Praveen Veerabhadrappa; Sheara T Williamson; Chenyi Ling; Hojun Lee; Heather Grimm; Sunny R Thakkar; Deborah L Crabbe; Mohammed A Kashem; Michael D Brown Journal: Menopause Date: 2014-06 Impact factor: 2.953